series-c-plus
Stage
3
Investors
About
Medasense develops medical devices and AI-based monitoring technology that quantifies nociception to assess and manage pain in patients who cannot communicate, focusing on intraoperative and critical care settings.
Explore Medasense's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.